Outcomes of splenectomy versus cladribine for hairy cell leukemia in resource limited settings.

The article reports on research which was conducted to investigate the outcomes of splenectomy versus cladribine for the treatment of hairy cell leukemia in settings with limited resources. Researchers evaluated the cases of 43 patients at an Indian hospital between 2001 and 2012. They cautiously concluded that splenectomy may still be considered as an alternative to cladribine for hairy cell leukemia in countries with limited resources.